GİRİŞ VE AMAÇ

64. Miura H., Nishimura K., Tsujimura A., Matsumiya K., Matsumoto K., Nakamura T. et
al. Effects of hepatocyte growth factor on e-cadherin-mediated cell-cell adhesion in
DU145 prostate cancer cells. Urology 2002; 58: 1064-9.
65. Dai J., Shen R., Sumitomo M., Goldberg J.S., Geng Y., Navarro D. Tumorsuppressive
effects of neutral endopeptidase in androgen-independent prostate cancer
cells. Clinical Cancer Research May 2001; Vol 7: 1370-7.
66. Song J, Aumuller G, Xiao F, Wilhelm B, Albrecht M.Cell specific expression of
CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells. Prostate
2004 Mar 1; 58(4): 394-405.
67. Tawfic S, Niehans G.A., Manivel J.C. The pattern of CD10 expression in selected
pathologic entities of the prostate gland. Hum Pathol 2003; 34: 450-6.
68. Iwaya K., Ogawa H., Izumi M., Kuroda M., Mukai K. Stromal expression of CD10 in
invasive breast carcinoma: a new predictor of clinical outcome. Virchows Archiv
2002; http://springerlink.metapress.com.
69. Amant F., Steenkiste E., Schurmans K., Verbist L., Abeler V.M., Tulunay G. et al.
Immunohistochemical expression of CD10 antigen in uterina adenosarcoma.
International Journal of Gynecological Cancer 2004; Volume 14, Page 6;
http://www.blackwell-synergy.com.
70. Koufmann O., Flath B., Spath-Schwalbe E., Possinger K., Dietel M.
Immunohistochemical detection of CD10 with monoclonal antibody 56C6 on parafin
section. Am J Clin Pathol 1999 Jun; 111(1): 117-122.
71. Comman acute lymphocytic leukemia antigen (CALLA). 2004. www.scimedweb.com.
72. CD10/CALLA (neutral endopeptidase) ab-2. 2004. www.labvision.com.
73. Shipp M.A., Look T.A. Hematopoietic Differentiation antigens that are membraneassociated
enzymes: cutting is the key!. Blood 15 August 1993; Vol 82,No 4: 1052-70.
74. Nagakawa O., Ogasawara M., Murata J., Fusee H., Saiki I. Effect of prostatic
neuropeptides on migration of prostate cancer cell lines. İnternational Journal of
Urology 2001; 8: 65-70.
75. Salido M., Vilches J., Lopez A., Romans G.M. Neuropeptides bombesin and
calcitonin ınhibit apoptosis-related elemental changes in prostate carcinoma cell lines.
Cancer January 15 2002; Volume 94: Number 2.
76. Freedland S.J., Seligson D.B., Liu A.Y., Pantuck A.J., Paik S.H., Horvaths W.J. A.
Loss of CD10 (neutral endopeptidase) ıs a frequent and early event in human prostate
cancer. Prostate 2003 Apr 1; 55(1): 71-80.
59